series-b
Stage
3
Investors
About
Noema Pharma is a clinical-stage biotech developing oral small molecule therapeutics targeting neurological and related disorders, including treatments for trigeminal neuralgia and menopause-related symptoms.
Explore Noema Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.